The bipartisan leaders of the US Senate had finally agreed to end the partial shutdown of the United States and raise its borrowing authority, said a report from Bloomberg.
North America
Cuban found innocent of insider trading charges
A verdict of not guilty was entered by a Dallas jury on the case of insider trading against billionaire Mark Cuban.
New executives to lead Toys R Us for the coming holiday shopping season
A permanent CEO and a new President for US business was recently installed by the board of directors of Toys R Us.
GI Partners acquires Regent Commons
GI Partners' Datacore LP acquires Regent Commons, a property with LEED certification located near the Dallas Fort Worth International Airport.
FF&P Private Equity sells off OB10 to Tungsten Corp
OB10 is sold to Tungsten Corp for GBP100 million. The direct investment arm of the Fleming Family & Partners, FF&P Private Equity, had announced the sale of OB10 to Tungsten Corp for the sum of GBP100 million.
Latest News
Renaissance Capital had announced the launch of an exchanged-traded fund (ETF) IPO on the NYSE Arca Exchange.
The quarterly report on angel group investment activities was recently released. A national survey of angel group investment activity was reported in the Q2 2013 Halo Report.
People familiar with the matter told Bloomberg that Edgewood Partners was looking for bidders for the insurance firm.
Imperial Capital Group backed STI Technologies with a USD 17 million investment. Toronto-based Imperial Capital Group announced its USD 17 million investment in reimbursement card provider STI Technologies.
According to a Techcrunch report, the initial public offering of enterprise cloud provider Veeva Systems saw its shares climbed almost 84% and had raised USD194 million.
500 Startups said in its recent US Securities and Exchange Commission filing that it would raise USD100 million to increase its investment in early-stage startups and put additional investment in startups it had already supported.
Pharmaceutical firm G1 Therapeutics scored USD 12.5 million from MedImmune Ventures and other investors in its Series A funding round.
Texas-based private equity firm Cotton Creek Capital bought Royal Baths Manufacturing for an undisclosed amount.
Biopharmaceutical firm SAGE Therapeutics scored USD 20 million from ARCH Venture Partners and Third Rock Ventures in its Series B funding round.
